Statistics on Biotechnology Use  
Results by sector of operation
Company sector.  Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production
Unidades: specified in variables

,Total,Main,Secondary dwellings,Tool,
Companies that carry out R&D in Biotechnology,1.078,526,173,379,
%Companies according to biotechnology used: Genetic code,35,45,22,27,
%Companies according to biotechnology used: Functional units,42,52,37,30,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,27,34,22,19,
%Companies according to biotechnology used: Bioprocesses,49,43,51,56,
%Companies according to biotechnology used: Sub-cellular organisms,8,12,6,4,
%Companies according to biotechnology used: Bio-computing,22,33,17,9,
%Companies according to biotechnology used: Nanobiotechnology,14,19,15,6,
%Companies according to biotechnology used: Other,12,13,14,10,
%Company by field(s) of ultimate application of biotechnology use: Human Health,48,68,39,25,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,20,21,20,19,
%Company by field(s) of ultimate application of biotechnology use: Food products,33,26,30,44,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,24,22,28,25,
%Company by field(s) of ultimate application of biotechnology use: Environment,15,12,26,14,
%Company by field(s) of ultimate application of biotechnology use: Industry,14,14,20,9,
Personnel in R&D in biotechnology (no. of persons),10.191,5.753,1.481,2.956,
Personnel in R&D in biotechnology (no. of persons): Researchers,5.774,3.440,849,1.485,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,4.417,2.314,632,1.471,
Personnel in R&D in biotechnology (no. of persons): women,5.525,3.332,769,1.424,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,3.015,1.902,419,694,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,2.511,1.431,350,730,
Personnel in R&D in biotechnology (FTE),7.191,4,4.611,5,889,5,1.690,4,
Personnel in R&D in biotechnology (FTE): Researchers,4.276,6,2.783,2,566,927,5,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,2.914,7,1.828,3,323,5,763,
Personnel in R&D in biotechnology (FTE): women,3.985,4,2.631,7,473,6,880,2,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2.234,1.505,4,276,8,451,8,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.751,4,1.126,3,196,7,428,4,
Internal expenditure on R&D (thousands of euros),578.171,392.202,77.155,108.814,
1) By nature of the expense: Current expenses,517.601,345.782,70.758,101.061,
1.1) Remuneration to researchers,213.755,144.473,30.720,38.563,
1.2) Remuneration to technicians and assistants,98.440,61.637,11.993,24.810,
1.3) Other current expenses,205.406,139.672,28.045,37.689,
2) By nature of the expense: Capital expenses,60.570,46.420,6.397,7.753,
2.1) Land and buildings,22.609,21.900,79,630,
2.2) Equipment and instruments,36.169,23.279,6.254,6.636,
2.3) Acquisition of specific R+D software,1.793,1.242,63,488,
1) By origin of the funds: National funds,487.615,312.995,69.889,104.731,
1.1) Own funds,330.459,205.081,45.123,80.255,
1.2) From companies,45.462,23.837,13.797,7.827,
1.3) Public Administration funds,66.189,40.409,10.721,15.060,
1.4) From Universities,25.148,25.101,32,15,
1.5) From non profit private institutions,20.357,18.567,216,1.575,
1) By origin of the funds: Foreign funds,90.556,79.207,7.266,4.083,
2.1) From EU programmes,20.932,15.392,3.369,2.172,
2.2) Other foreign funds,69.624,63.816,3.897,1.911,
Purchase of R&D services in biotechnology (thousands of euros),166.022,131.839,27.652,6.530,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,97.455,77.835,14.188,5.432,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,68.567,54.005,13.464,1.098,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,46,56,45,33,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,12,17,13,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,14,14,19,12,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,14,14,22,10,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets,17,20,23,12,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels,17,20,21,11,
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception,18,18,23,17,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,35,39,41,28,
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost,49,54,49,41,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,21,21,21,21,
% Companies that have requested biotechnology patents,15,24,10,7,
Number of patents requested,526,397,72,57,
% Companies with income of an international origin related to biotechnological activities,26,35,9,12,8,18,2,
% Turnover representing income of an international origin related to biotechnological activities,1,4,11,7,.,0,9,
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU,63,8,66,2,73,49,7,
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries,36,2,33,8,27,1,50,3,
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services,91,6,91,3,64,7,95,1,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,0,9,0,6,.,3,1,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,9,1,6,34,9,1,4,
% Income of an international origin related with activities according to the classification: Other,5,6,6,6,0,4,0,5,
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute